MedTrace Logo

Malmö Breast Tomosynthesis Screening Trial

NCT01091545 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15000

Last updated 2019-11-13

No results posted yet for this study

Summary

To compare digital breast tomosynthesis (DBT) with full field digital mammography (FFDM) regarding effectiveness as screening modalities.

Conditions

Interventions

RADIATION

DBT and FFDM

Women in the study will once undergo both standard FFDM screening (2-views) and DBT (1 view, MLO). This will result in a doubled radiation dose compared to only 2-view FFDM, which is the standard procedure for women in the screening program.

Sponsors & Collaborators

  • Unilabs AB Sweden

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Principal Investigators

  • Sophia Zackrisson, MD PhD · Region Skane

  • Ingvar Andersson, MD PhD · Lund University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-01
Primary Completion
2017-12-31
Completion
2019-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091545 on ClinicalTrials.gov